ANTIGENIC DETERMINANTS OF VARICELLA VIRUS
水痘病毒的抗原决定因素
基本信息
- 批准号:6373078
- 负责人:
- 金额:$ 28.41万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1985
- 资助国家:美国
- 起止时间:1985-09-01 至 2002-06-30
- 项目状态:已结题
- 来源:
- 关键词:antibody receptor antigen receptors confocal scanning microscopy gene mutation glycoproteins immunoelectron microscopy phosphorylation protein kinase protein purification protein transport site directed mutagenesis tissue /cell culture transfection varicella zoster virus virus antigen virus infection mechanism virus protein
项目摘要
DESCRIPTION (Adapted from Applicant's Abstract): Varicella-zoster virus
(VZV) is an evolutionarily ancient alphaherpesvirus with a 125 kbp genome.
VZV causes two diseases -- chickenpox and shingles; the latter disease is a
remarkable illustration of VZV neurotropism and reactivation from a
prolonged latency. The goal of the current proposal is an increased
understanding at a molecular level of the structure/function relationships
of the two unique short glycoproteins called gE and gI which form a Fc
receptor complex. The herpesviral gE/gI complex is known to be an important
determinant of viral egress and cell-to-cell spread, but the mechanisms are
not well understood. The Research Plan contains three Specific Aims. Aim 1
includes a characterization of the phosphorylation and sorting motifs in the
C-tail of gE. The glycoprotein receptor is modified by both serine and
tyrosine protein kinases; tyrosine phosphorylation occurs only on a dimeric
form of gE and has not been previously recognized. Phosphorylation will be
measured by both in vivo and in vitro protein kinase assays. The fact that
both serine and tyrosine phosphorylation motifs are common features of
several mammalian cell surface receptors supports the hypothesis that
VZVgE/gI form a pluripotential receptor complex. Aim 2 seeks through a
mutagenesis approach to further identify the serine protein kinase which
phosphorylates the unusual serine-proline-proline sequence in the C-tail of
gI, and also identify internalization motifs in proximity to the
phosphorylation site. In Aim 3, the interaction of the two components of
the gE/gI complex will be analyzed before and after mutagenesis in order to
determine the specific roles of each signaling motif on the function of the
entire complex. Endocytosis and recycling of the VZV gE/gI complex will be
investigated in detail. As a complementary strategy to transient
transfection assays, recombinant VZV gE-pseudorabies viruses will be
produced and evaluated in an animal model of neurotropism, and VZV mutants
with a gI null phenotype will be investigated by several imaging techniques,
including laser scanning confocal microscopy and electron microscopy with
immunolabeling. In summary, the phosphorylation modifications of VZV gE/gI
support an evolutionary link with other nonviral receptors and, at the same
time, suggest a role for phosphorylation-dephosphorylation events in
trafficking and endocytic pathways involved in viral egress and cell-to-cell
spread.
描述(改编自申请人的摘要):水痘-带状疱疹病毒
(VZV)是一种进化上古老的α疱疹病毒,具有125 kbp的基因组。
VZV引起两种疾病-水痘和带状疱疹;后一种疾病是一种
VZV嗜神经性和从一个细胞中再激活的显著例证
潜伏期延长 目前提案的目标是增加
在分子水平上理解结构/功能关系
在形成Fc的两种独特的短糖蛋白gE和gI中,
受体复合物 已知疱疹病毒gE/gI复合物是一种重要的
病毒外出和细胞间传播的决定因素,但其机制是
没有被很好地理解。 研究计划包含三个具体目标。 要求1
包括对磷酸化和分选基序的表征,
gE的C尾。 糖蛋白受体被丝氨酸和丝氨酸修饰,
酪氨酸蛋白激酶;酪氨酸磷酸化只发生在二聚体上。
它是一种gE,以前没有被发现。 磷酸化将是
通过体内和体外蛋白激酶测定来测量。 的事实
丝氨酸和酪氨酸磷酸化基序都是
几种哺乳动物细胞表面受体支持这一假设,
VZVgE/gI形成多能受体复合物。 目标2寻求通过
诱变方法,以进一步鉴定丝氨酸蛋白激酶,
磷酸化C-尾中不寻常的丝氨酸-脯氨酸-脯氨酸序列,
gI,并且还鉴定接近于Gl的内化基序。
磷酸化位点。 在目标3中,
在诱变前后分析gE/gI复合物,
确定每个信号基序对细胞功能的具体作用,
整个复杂。 VZV gE/gI复合物的内吞作用和再循环将被抑制。
详细调查。 作为瞬态的补充策略,
转染试验,重组VZV gE-伪狂犬病病毒将被
在嗜神经性的动物模型中产生和评价,以及VZV突变体
将通过几种成像技术研究gI无效表型,
包括激光扫描共聚焦显微镜和电子显微镜,
免疫标记。 总之,VZV gE/gI的磷酸化修饰
支持与其他非病毒受体的进化联系,同时
时间,表明磷酸化-去磷酸化事件在
参与病毒外出和细胞到细胞的运输和内吞途径
传播.
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Charles F. Grose其他文献
Charles F. Grose的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Charles F. Grose', 18)}}的其他基金
Wild-type allele found in varicella vaccine virus during severe herpes zoster
严重带状疱疹期间水痘疫苗病毒中发现野生型等位基因
- 批准号:
10038935 - 财政年份:2020
- 资助金额:
$ 28.41万 - 项目类别:
Autophagy and ER stress during varicella infection
水痘感染期间的自噬和内质网应激
- 批准号:
8427354 - 财政年份:2011
- 资助金额:
$ 28.41万 - 项目类别:
Autophagy and ER stress during varicella infection
水痘感染期间的自噬和内质网应激
- 批准号:
8232048 - 财政年份:2011
- 资助金额:
$ 28.41万 - 项目类别:
Autophagy and ER stress during varicella infection
水痘感染期间的自噬和内质网应激
- 批准号:
8803757 - 财政年份:2011
- 资助金额:
$ 28.41万 - 项目类别:
Autophagy and ER stress during varicella infection
水痘感染期间的自噬和内质网应激
- 批准号:
8101645 - 财政年份:2011
- 资助金额:
$ 28.41万 - 项目类别:
ACQUISITION OF HUMAN HERPES VIRUS-8 IN INFANCY
在婴儿期获得人类疱疹病毒 8
- 批准号:
7604837 - 财政年份:2007
- 资助金额:
$ 28.41万 - 项目类别:
IMMUNOSCANNING ELECTRON MICROSCOPY OF HERPES VIRUSES
疱疹病毒的免疫扫描电子显微镜
- 批准号:
6278480 - 财政年份:1998
- 资助金额:
$ 28.41万 - 项目类别:
IMMUNOSCANNING ELECTRON MICROSCOPY OF HERPES VIRUSES
疱疹病毒的免疫扫描电子显微镜
- 批准号:
6117285 - 财政年份:1998
- 资助金额:
$ 28.41万 - 项目类别:
DNA SEQUENCING--ITERATIVE STEPS BY PRODUCT REGENERATION
DNA 测序——产物再生的迭代步骤
- 批准号:
2889694 - 财政年份:1998
- 资助金额:
$ 28.41万 - 项目类别:
相似海外基金
Development of back bone vectors for chimeric antigen receptors against key molecules, CD47 and CD24, activating macrophages
开发针对关键分子 CD47 和 CD24 的嵌合抗原受体的骨干载体,激活巨噬细胞
- 批准号:
23K06728 - 财政年份:2023
- 资助金额:
$ 28.41万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
CAREER: Engineering next-generation chimeric antigen receptors for cancer immunotherapy using phospho-proteomics
职业:利用磷酸蛋白质组学设计用于癌症免疫治疗的下一代嵌合抗原受体
- 批准号:
2145853 - 财政年份:2022
- 资助金额:
$ 28.41万 - 项目类别:
Continuing Grant
Construction of a drug discovery platform utilizing antigen receptors that regulate the quality of cancer immunity
利用调节癌症免疫质量的抗原受体构建药物发现平台
- 批准号:
22K06603 - 财政年份:2022
- 资助金额:
$ 28.41万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Engineering synthetic adhesion receptors to enhance the sensitivity of therapeutic chimeric antigen receptors
工程合成粘附受体以增强治疗性嵌合抗原受体的敏感性
- 批准号:
MR/W031353/1 - 财政年份:2022
- 资助金额:
$ 28.41万 - 项目类别:
Research Grant
Modeling based design of chimeric antigen receptors for Natural Killer cell-based immunotherapy
用于基于自然杀伤细胞的免疫治疗的嵌合抗原受体的基于建模的设计
- 批准号:
10701754 - 财政年份:2022
- 资助金额:
$ 28.41万 - 项目类别:
Modeling based design of chimeric antigen receptors for Natural Killer cell-based immunotherapy
用于基于自然杀伤细胞的免疫治疗的嵌合抗原受体的基于建模的设计
- 批准号:
10557760 - 财政年份:2022
- 资助金额:
$ 28.41万 - 项目类别:
Chimeric antigen receptors on regulatory T cells as a treatment strategy in auto-immune diseases.
调节性 T 细胞上的嵌合抗原受体作为自身免疫性疾病的治疗策略。
- 批准号:
437200 - 财政年份:2020
- 资助金额:
$ 28.41万 - 项目类别:
Studentship Programs
Molecualr imaging for development of chimeric antigen receptors (CARs) resistant to T cell exhaustion
用于开发抗 T 细胞耗竭的嵌合抗原受体 (CAR) 的分子成像
- 批准号:
20H03536 - 财政年份:2020
- 资助金额:
$ 28.41万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Therapeutic Anti-HIV Chimeric Antigen Receptors Via Stem Cell Delivery
通过干细胞递送治疗性抗 HIV 嵌合抗原受体
- 批准号:
10542442 - 财政年份:2020
- 资助金额:
$ 28.41万 - 项目类别:
Therapeutic Anti-HIV Chimeric Antigen Receptors Via Stem Cell Delivery
通过干细胞递送治疗性抗 HIV 嵌合抗原受体
- 批准号:
10321545 - 财政年份:2020
- 资助金额:
$ 28.41万 - 项目类别: